INDV
- Indivior PLC
()
Overview
Company Summary
Indivior PLC is a specialized pharmaceutical company that focuses on developing innovative treatments for addiction and related mental health disorders. The company primarily works in the field of opioid addiction, aiming to provide effective and accessible solutions for individuals struggling with this condition.
Indivior's core offering is its portfolio of products that help patients overcome opioid dependence. Their flagship product is Suboxone, which combines buprenorphine and naloxone to reduce opioid withdrawal symptoms and cravings. This medication is administered as a film placed under the tongue, offering a discreet and convenient treatment option.
The company also provides support services for patients, including education, counseling, and behavioral therapy. Indivior recognizes that addiction is a complex issue and advocates for a holistic approach that combines medication with psychosocial support.
In addition to their focus on opioid addiction, Indivior is expanding their portfolio to address other substance use disorders and mental health conditions. They are actively investing in research and development to identify and develop new treatment options in these areas.
Indivior operates globally, with a presence in over 40 countries. They collaborate with healthcare professionals, governments, and advocacy organizations to raise awareness and improve access to treatment for those in need. By tackling addiction and related mental health disorders, Indivior aims to make a positive impact on individuals, families, and communities worldwide.